With this model, researchers may be able to discover antibody drugs capable of targeting a wide range of infectious diseases.
Absci Corporation (NASDAQ: ABSI), a data-first generative AI drug creation company, and Owkin, a TechBio that uses agentic AI to unlock complex targets for drug discovery, development, and diagnostics ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback